Marc‐Eric Halatsch

Molecular Modes of Action of Artesunate in Tumor Cell Lines

Thomas Efferth, Axel Sauerbrey, Armin Olbrich et al. · Molecular Pharmacology · 2003 · 432 citations

Life Sciences, Oncology, Pharmacology +7

Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma.

Martin Höhne, Marc‐Eric Halatsch, Georg F. Kahl et al. · PubMed · 1992 · 128 citations

Medicine, Genetics, Oncology +16

CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide

Richard E. Kast, Georg Karpel‐Massler, Marc‐Eric Halatsch · Oncotarget · 2014 · 117 citations · Full text

Medicine, Oncology, Pharmacology +15

Intracranial dermoid cysts: variations of radiological and clinical features

Berk Orakcioglu, Marc‐Eric Halatsch, Mathias Fortunati et al. · Acta Neurochirurgica · 2008 · 111 citations

Medicine, Dermatology, Pathology +12

The effects of PI3K-mediated signalling on glioblastoma cell behaviour

Julia Langhans, Lukas Schneele, Nancy Trenkler et al. · Oncogenesis · 2017 · 86 citations · Full text

Medicine, Oncology, Pharmacology +17